Laddar...
Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy
Combination antiretroviral therapy (cART) given orally has transformed HIV from a terminal illness to a manageable chronic disease. Yet despite the recent development of newer and more potent drugs for cART and suppression of virus in blood to undetectable levels, residual virus remains in tissues....
Sparad:
| I publikationen: | Eur J Pharm Biopharm |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6482852/ https://ncbi.nlm.nih.gov/pubmed/29678735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejpb.2018.04.014 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|